Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Monday Links

Posted on August 21, 2023August 21, 2023 by John C. Goodman
  • Oregon hospital threatens to refuse Medicare Advantage patients.
  • Ten drugs, mostly used to treat rare diseases cost over $700,000 annually.
  • How Big Pharma makes its money: AbbVie blanketed Humira, the best-selling drug in history, with 165 peripheral patents, to deter any possible competition.
  • Medicine without doctors:  The past several years have seen hundreds of laws proposing to expand non doctor medical professionals’ work, the AMA has spent millions of dollars fighting back. (Washington Post)
+

The FDA Hinders the Progress of Regenerative Medicine

Posted on August 20, 2023 by Devon Herrick

The U.S. Food and Drug Administration (FDA) sometimes gets lost in a bureaucratic maze of confusion and red tape that deprives patients of beneficial therapies. Innovative products sometimes fall within a gray area and become overly regulated. One of the FDA’s latest targets is regenerative medicine.

An article titled, An MBA in Regulatory Confusion, talks about Florida-based Regenative Labs. The firm manufactures products made from umbilical cords (donated by mothers after a C-section, according to the company website). English physician and anatomist Thomas Wharton first described his namesake umbilical cord jelly in 1656, although he had no way of knowing it is rich in stem cells and regenerative healing properties.

+

The New Weight Loss Drugs

Posted on August 18, 2023August 18, 2023 by John C. Goodman

It’s early, but nothing like these drugs has existed before… In fact, much about the drugs remains shrouded in mystery. Researchers discovered by accident that exposing the brain to a natural hormone at levels never seen in nature elicited weight loss. They really don’t know why, or if the drugs may have any long-term side effects.

+

Thursday Links

Posted on August 17, 2023August 17, 2023 by John C. Goodman

JAMA study: Air pollution associated with dementia. The study is behind a paywall, but if this is a typical medical study, no one asked if the parents or grandparents had dementia.

State CON regulations are hurting patients.

Where the highest-paid doctors live: South Dakota, North Dakota, Alaska, and Wyoming.

Tyler Cowen has an explanation for this: Rural America has about 20 percent of the U.S. population but about 10 percent of its doctors.

Bird flu in Finland has pandemic potential.

Different doses of prescription drugs for men and women? Believe it or not, some people want to debate that.

Medicare negotiation is likely to lower the future price of only 4 of the 10 most likely targeted drugs.

+
  • Previous
  • 1
  • …
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 244
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 44 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom